Mehmet Akçe

Mehmet Akçe

Emory University - Atlanta / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1357097
person_outline Mehmet Akçe's MOST POPULAR ARTICLES
1-) Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a …RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ...The Lancet 401 (10391), 1853-1865, 20233022023
2-) Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanismsIH Sahin, M Akce, O Alese, W Shaib, GB Lesinski, B El-Rayes, C WuBritish journal of cancer 121 (10), 809-818, 20192942019
3-) Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trialJM Llovet, M Kudo, P Merle, T Meyer, S Qin, M Ikeda, R Xu, J Edeline, ...The Lancet Oncology 24 (12), 1399-1410, 20231672023
4-) The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced‐stage cancer treated with immunotherapyMA Bilen, DJ Martini, Y Liu, C Lewis, HH Collins, JM Shabto, M Akce, ...Cancer 125 (1), 127-134, 20191482019
5-) The potential of CAR T cell therapy in pancreatic cancerM Akce, MY Zaidi, EK Waller, BF El-Rayes, GB LesinskiFrontiers in immunology 9, 2166, 20181292018